Jyothy Labs Limited (JYOTHYLAB) AI Stock Analysis

• Market Cap: ₹95.75B
• Dividend Yield: 1.24%
• Average Volume (3M): 26.54K
• Price to Earnings (P/E): 27.5
• Beta (1Y): 0.81
• Revenue Growth: 1.62%
• EPS Growth: -7.32%
• Country: IN
• Employees: 2,943
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 2.40
• Shares Outstanding: 367,214,500
• 10 Day Avg. Volume: 19,687
• 30 Day Avg. Volume: 26,541
• PEG Ratio: 109.35
• Price to Book (P/B): 5.89
• Price to Sales (P/S): 4.21
• P/FCF Ratio: 47.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: ₹319.00 ▲(15.41% Upside)

Jyothy Labs Limited's overall stock score is primarily driven by its strong financial performance, characterized by consistent revenue and profit growth, effective cost management, and solid cash flow generation. However, the technical analysis indicates bearish momentum, with the stock trading below key moving averages and showing oversold conditions. The valuation suggests the stock may be overvalued, with a high P/E ratio and modest dividend yield. These factors collectively result in a moderate overall stock score.

Positive Factors

Revenue Growth

The consistent revenue growth over the years indicates strong market demand and effective sales strategies, supporting long-term business expansion.

Cost Management

Improved gross profit margins reflect efficient cost management and pricing strategies, which enhance profitability and competitive positioning.

Debt Management

Effective debt management with a reduced debt-to-equity ratio strengthens the balance sheet, providing financial stability and flexibility for future growth.

Negative Factors

Equity Financing Reliance

A high reliance on equity financing may restrict leverage benefits, potentially limiting the company's ability to capitalize on growth opportunities through debt.

Operating Cash Flow Decline

The decline in operating cash flow suggests potential challenges in cash generation, which could impact the company's ability to fund operations and investments efficiently.

EBIT Margin Volatility

Volatility in EBIT margins may indicate fluctuating operational efficiency, which could affect profitability and require strategic adjustments to stabilize margins.

Jyothy Labs Limited Business Overview & Revenue Model

Company Description

Jyothy Labs Limited, together with its subsidiaries, engages in manufacturing and marketing fabric care, dishwashing, personal care, and household insecticides products in India and internationally. The company operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, Laundry Services, and Others segments. The Dishwashing segment offers dish wash scrubbers and scrubber steel, as well as dish wash bars, liquids, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, fabric enhancers, bar soaps, and detergent powders under the Henko, Mr. White, Ujala, and More light brands. The Household Insecticides segment offers mosquito repellent coils, liquids, and cards, as well as insect repellents and air care products under the Maya, T- Shine, and Maxo brands. The Personal Care segment provides body soaps, face washes, toothpastes, deodorants, talcum powders, after shave products, hand sanitizers, and moisturizers under the Margo, Fa, and Neem Active brands. The Laundry Services segment provides dry cleaning and laundry services. The Others segment offers incense sticks, toilet and vegetable cleaner and floor shine products under the Joy of shine brand. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. Jyothy Labs Limited was founded in 1983 and is based in Mumbai, India.

How the Company Makes Money

Jyothy Labs generates revenue primarily through the sale of its consumer products in domestic and international markets. The company's revenue model is based on the direct sale of branded goods through various distribution channels, including modern retail, traditional trade, and e-commerce platforms. Key revenue streams include fabric care products (such as detergents and fabric whiteners), personal care products (soaps and shampoos), and insecticides (mosquito repellents). Additionally, JYOTHYLAB benefits from strong brand recognition and customer loyalty, which drive repeat purchases. Strategic partnerships with distributors and retailers enhance its market reach and visibility. The company also focuses on innovation and product development, launching new products that cater to changing consumer preferences, further contributing to its earnings.

Jyothy Labs Limited Financial Statement Overview

Summary

Jyothy Labs Limited exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet is robust with low leverage, although a high equity ratio could limit financial flexibility. The company should focus on maintaining cash flow efficiency to sustain growth momentum.

Income Statement

Jyothy Labs Limited shows strong revenue growth with a consistent increase from INR 17,097 million in 2020 to INR 28,469 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management and pricing strategies. Net profit margin has also remained stable, contributing to overall profitability. The EBIT and EBITDA margins reflect robust operational efficiency. However, attention is needed on the slight volatility in EBIT margins over the years.

Balance Sheet

The company maintains a solid balance sheet with a favorable debt-to-equity ratio, decreasing from 0.27 in 2020 to 0.03 in 2025, showcasing effective debt management and strong equity base. The return on equity is commendable, enhancing investor confidence. However, the equity ratio suggests a high reliance on equity financing, which could limit leverage benefits.

Cash Flow

Jyothy Labs has demonstrated strong cash flow generation with positive free cash flow growth. The operating cash flow to net income ratio indicates efficient conversion of income into cash, although there was a decline in operating cash flow in recent years. The company's free cash flow to net income ratio is solid, reflecting effective capital expenditure management. However, the decline in operating cash flow from 2024 to 2025 suggests potential challenges in cash generation operations.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	28.78B	28.68B	27.61B	24.86B	21.97B	19.10B
Gross Profit	14.19B	14.39B	13.48B	10.42B	9.06B	8.92B
EBITDA	4.94B	5.05B	4.74B	3.08B	2.39B	3.09B
Net Income	3.65B	3.70B	3.69B	2.40B	1.62B	1.99B
Balance Sheet
Total Assets	0.00	26.91B	24.01B	20.62B	20.23B	19.56B
Cash, Cash Equivalents and Short-Term Investments	5.99B	5.99B	6.16B	2.81B	2.09B	1.94B
Total Debt	0.00	612.80M	505.60M	465.30M	1.71B	1.67B
Total Liabilities	-20.50B	6.41B	5.91B	5.11B	6.20B	5.65B
Stockholders Equity	20.50B	20.50B	18.08B	15.49B	14.44B	14.29B
Cash Flow
Free Cash Flow	0.00	2.53B	4.21B	2.93B	1.77B	3.76B
Operating Cash Flow	0.00	3.11B	4.58B	3.29B	2.03B	4.02B
Investing Cash Flow	0.00	-1.61B	-3.44B	-482.90M	-317.13M	-1.29B
Financing Cash Flow	0.00	-1.57B	-1.35B	-2.51B	-1.67B	-2.16B

Jyothy Labs Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 276.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Negative. The current price of 276.4 is below the 20-day moving average (MA) of 280.21, below the 50-day MA of 294.45, and below the 200-day MA of 325.79, indicating a bearish trend. The MACD of -6.32 indicates Positive momentum. The RSI at 27.26 is Positive, neither overbought nor oversold. The STOCH value of 11.05 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JYOTHYLAB.

Jyothy Labs Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BECTORFOOD	66 Neutral	₹70.82B	51.95	―	0.45%	10.82%	-8.21%
ZYDUSWELL	66 Neutral	₹141.63B	55.89	―	0.28%	14.55%	-20.61%
CCL	63 Neutral	₹125.76B	37.14	―	0.52%	30.11%	23.22%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
JYOTHYLAB	61 Neutral	₹95.75B	27.49	―	1.24%	1.62%	-7.32%
GALAXYSURF	60 Neutral	₹69.17B	24.15	―	1.07%	22.63%	-8.57%
HONASA	54 Neutral	₹94.49B	71.78	―	―	10.59%	67.55%

Jyothy Labs Limited Corporate Events

Jyothy Labs Releases Un-audited Financial Results for September 2025

Jyothy Labs Limited announced the approval of its un-audited financial results for the quarter and half-year ending September 30, 2025, following a board meeting held on November 12, 2025. The results, reviewed by the company’s statutory auditors, comply with the SEBI regulations, ensuring transparency and adherence to Indian accounting standards. This announcement is significant for investors and stakeholders as it provides insights into the company’s financial health and operational performance during the specified period.